The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Mechanism by Which Orally Administered β-1,3-Glucans Enhance the Tumoricidal Activity of Antitumor Monoclonal Antibodies in Murine Tumor Models
Abstract
Antitumor mAb bind to tumors and activate complement, coating tumors with iC3b. Intravenously administered yeast β-1,3;1,6-glucan functions as an adjuvant for antitumor mAb by priming the inactivated C3b (iC3b) receptors (CR3; CD11b/CD18) of circulating granulocytes, enabling CR3 to trigger cytotoxicity of iC3b-coated tumors. Recent data indicated that barley β-1,3;1,4-glucan given orally similarly potentiated the activity of antitumor mAb, leading to enhanced tumor regression and survival. This investigation showed that orally administered yeast β-1,3;1,6-glucan functioned similarly to barley β-1,3;1,4-glucan with antitumor mAb. With both oral β-1,3-glucans, a requirement for iC3b on tumors and CR3 on granulocytes was confirmed by demonstrating therapeutic failures in mice deficient in C3 or CR3. Barley and yeast β-1,3-glucan were labeled with fluorescein to track their oral uptake and processing in vivo. Orally administered β-1,3-glucans were taken up by macrophages that transported them to spleen, lymph nodes, and bone marrow. Within the bone marrow, the macrophages degraded the large β-1,3-glucans into smaller soluble β-1,3-glucan fragments that were taken up by the CR3 of marginated granulocytes. These granulocytes with CR3-bound β-1,3-glucan-fluorescein were shown to kill iC3b-opsonized tumor cells following their recruitment to a site of complement activation resembling a tumor coated with mAb.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579
Dectin-1 Mediates the Biological Effects of β-Glucans
Brown, G. D., Herre, J., Williams, D. L., Willment, J. A., Marshall, A. S. J., & Gordon, S. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021890 · Cited by 1,205
Dectin-1 Is A Major β-Glucan Receptor On Macrophages
Brown, G. D., Taylor, P. R., Reid, D. M., Willment, J. A., Williams, D. L., Martinez-Pomares, L., Wong, S. Y. C., & Gordon, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020470 · Cited by 1,014
Keating, M. J., Flinn, I., Jain, V., Binet, J.-L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3554 · Cited by 948
Fungal β-Glucans and Mammalian Immunity
Brown, G. D., & Gordon, S. (2003) · Immunity · doi:10.1016/s1074-7613(03)00233-4 · Cited by 665
Taylor, P. R., Brown, G. D., Reid, D. M., Willment, J. A., Martinez-Pomares, L., Gordon, S., & Wong, S. Y. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3876 · Cited by 655
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).
Sliwkowski, M. X., Ja, L., Gd, L., Te, H., FENDLY, B. M., & Fox, J. A. (1999) · PubMed · Cited by 653
Thornton, B. P., Vĕtvicka, V, Pitman, M., Goldman, R. C., & Ross, G. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1235 · Cited by 589
Self-citationDiamond, M. S., Garcia-Aguilar, J., Bickford, J. K., Corbi, A. L., & Springer, T. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.4.1031 · Cited by 533
Herbst, R. S., & Shin, D. M. (2002) · Cancer · doi:10.1002/cncr.10372 · Cited by 446
Mushrooms, Tumors, and Immunity
Borchers, A. T., Stern, J. S., Hackman, R. M., Keen, C. L., & Gershwin, M. E. (1999) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-86.x · Cited by 419
Targeting the epidermal growth factor receptor for cancer therapy.
Mendelsohn, J. M. (2002) · PubMed · Cited by 414
Vetvicka, V, Thornton, B. P., & Ross, G. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118777 · Cited by 407
Self-citationThe use of mushroom glucans and proteoglycans in cancer treatment.
Kidd, P. M. (2000) · PubMed · Cited by 347
Mechanism of action of rituximab
Cerny, T., Borisch, B., Introna, M., Johnson, P., & Rose, A. L. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200211002-00002 · Cited by 287
Xia, Y., Vetvicka, V., Yan, J., Hanikýřová, M., Mayadas, T. N., & Ross, G. D. (1999) · PubMed · Cited by 265
Self-citationThe mechanisms of action of rituximab in the elimination of tumor cells
Johnson, P., & Glennie, M. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50025 · Cited by 247
Xia, Y., Větvička, V., Yan, J., Hanikýřová, M., Mayadas, T., & Ross, G. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2281 · Cited by 244
Self-citationMolecular Characterization of Defective Antigen Processing in Human Prostate Cancer
Sanda, M. G., Restifo, N. P., Walsh, J. C., Kawakami, Y., Nelson, W. G., Pardoll, D. M., & Simons, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.280 · Cited by 235
Specificity of Membrane Complement Receptor Type Three (CR3) for ß-Glucans
Ross, G. D., Cain, J. A., Myones, B. L., Newman, S. L., & Lachmann, P. J. (1987) · Complement · doi:10.1159/000463010 · Cited by 226
Self-citationRegulation of the Adhesion versus Cytotoxic Functions of the Mac-1/CR3/αMβ2 - lntegrin Glycoprotein
Ross, G. D. (2000) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v20.i3.20 · Cited by 217
Self-citationTsukagoshi, S. (1984) · Cancer Treatment Reviews · doi:10.1016/0305-7372(84)90005-7 · Cited by 213
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
Hicklin, D. J., Wang, Z., Arienti, F., Rivoltini, L., Parmiani, G., & Ferrone, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci498 · Cited by 198
Mushrooms, Tumors, and Immunity
Borchers, A. T., Stern, J. S., Hackman, R. M., Keen, C. L., & Gershwin, M. E. (1999) · Experimental Biology and Medicine · doi:10.3181/00379727-221-44412 · Cited by 198
Chemoprevention of Breast Cancer: A Model for Change
Jordan, V. C., & Morrow, M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.1 · Cited by 197
Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies
Cheung, N.-K. V., Modak, S., Vickers, A., & Knuckles, B. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0321-3 · Cited by 180
Self-citationTrastuzumab: hopes and realities
Leyland-Jones, B. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00676-9 · Cited by 169
Hong, F., Hansen, R., Yan, J., Allendorf, D. J., Baran, J., Ostroff, G. R., & Ross, G. D. (2003) · PubMed · Cited by 165
Self-citationSpiridon, C., Ghetie, M.-A., Uhr, J. W., Marcheş, R., Li, J. L., Shen, G. L., & Vitetta, E. S. (2002) · PubMed · Cited by 157
Hank, J. A., Robinson, R. R., Surfus, J. E., Mueller, B. M., Reisfeld, R. A., Cheung, N. K., & Sondel, P. M. (1990) · PubMed · Cited by 151
Self-citationYan, J., Větvička, V., Xia, Y., Coxon, A., Carroll, M. C., Mayadas, T. N., & Ross, G. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3045 · Cited by 149
Self-citationChemosensitivity testing of human neoplasms using the soft agar colony assay
Schlag, P., & Flentje, D. (1984) · Cancer Treatment Reviews · doi:10.1016/0305-7372(84)90052-5 · Cited by 144
Yan, J., Větvička, V., Xia, Y., et al. (1999) · PubMed · Cited by 140
Self-citationSoares, M., Mehta, V., & Finn, O. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6555 · Cited by 135
Xia, Y., & Ross, G. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7285 · Cited by 112
Self-citationImmunomodulation by orally administered β-glucan in mice
Suzuki, I., Hashimoto, K., Ohno, N., Tanaka, H., & Yadomae, T. (1989) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(89)90130-6 · Cited by 109
Porgador, A., Mandelboim, O., Restifo, N. P., & Strominger, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13140 · Cited by 109
Xia, Y., & Ross, G. D. (1999) · PubMed · Cited by 100
Self-citationRoss, G. D., Thompson, R., Walport, M. J., Springer, T., Watson, J. V., Ward, R., Lida, J., Newman, S. L., Harrison, R. A., & Lachmann, P. J. (1985) · Blood · doi:10.1182/blood.v66.4.882.882 · Cited by 94
Self-citationCheung, N. V., & Modak, S. I. (2002) · PubMed · Cited by 92
Self-citationRole of Complement Receptor Type Three and Serum Opsonins in the Neutrophil Response to Yeast
Cain, J. A., Newman, S. L., & Ross, G. D. (2017) · Complement · doi:10.1159/000463011 · Cited by 77
Self-citationVětvička, V., Thornton, B. P., Wieman, T. J., & Ross, G. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.599 · Cited by 73
Self-citationPerspectives on Anti-HER Monoclonal Antibodies
Ranson, M., & Sliwkowski, M. X. (2002) · Oncology · doi:10.1159/000066203 · Cited by 63
Lentinan potentiates immunity and prolongs the survival time of some patients.
Matsuoka, H., Seo, Y., WAKASUGI, H., Saito, T., & Tomoda, H. (1997) · PubMed · Cited by 51
A Personal History of the CAMPATH-1H Antibody
Waldmann, H. (2002) · Medical Oncology · doi:10.1385/mo:19:2s:s03 · Cited by 50
Antitumor action of shiitake(Lentinus edodes) fruit bodies orally administered to mice.
Nanba, H., Kanichi, M. O. R. I., TOYOMASU, T., & KURODA, H. (1987) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.35.2453 · Cited by 50
Taguchi, T. (1987) · PubMed · Cited by 43
SUZUKI, I., Sakurai, T., Hashimoto, K., OIKAWA, S., Masuda, A., OHSAWA, M., & Yadomae, T. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.1606 · Cited by 40
Cited by
Dectin-1 is required for β-glucan recognition and control of fungal infection
Taylor, P. R., Tsoni, S. V., Willment, J. A., Dennehy, K. M., Rosas, M., Findon, H., Haynes, K., Steele, C., Botto, M., Gordon, S., et al. (2007) · Nature Immunology · doi:10.1038/ni1408 · Cited by 1,161
Dectin-1: a signalling non-TLR pattern-recognition receptor
Brown, G. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1745 · Cited by 1,158
The effects of β-glucan on human immune and cancer cells
Chan, G. C.-F., Chan, W. K., & Sze, D. M.-Y. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-25 · Cited by 862
β‐glucan recognition by the innate immune system
Goodridge, H. S., Wolf, A. J., & Underhill, D. M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00793.x · Cited by 688
Dietary modulation of immune function by β-glucans
Volman, J. J., Ramakers, J. D., & Plat, J. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.045 · Cited by 523
Metadata
- Authors
- Hong, F., Yan, J., Baran, J. T., Allendorf, D. J., Hansen, R. D., Ostroff, G. R., Xing, P. X., Cheung, N.-K. V., & Ross, G. D.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-07
- Volume
- 173
- Issue
- 2
- Pages
- 797-806
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2108093856
- Cited by
- 472
- References
- 48
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.